ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,485,148 | -6.4% | 34,728 | -9.2% | 0.75% | -7.0% |
| Q1 2023 | $2,655,254 | -3.7% | 38,250 | -5.9% | 0.80% | +0.1% |
| Q4 2022 | $2,756,206 | -31.9% | 40,652 | -49.8% | 0.80% | +34.4% |
| Q4 2020 | $4,049,000 | -10.4% | 80,997 | -1.8% | 0.60% | -26.6% |
| Q3 2020 | $4,519,000 | +5.0% | 82,461 | +1.8% | 0.82% | -7.3% |
| Q2 2020 | $4,305,000 | +10.0% | 81,027 | -7.5% | 0.88% | -40.7% |
| Q1 2020 | $3,912,000 | -19.6% | 87,595 | -10.2% | 1.48% | -7.7% |
| Q4 2019 | $4,864,000 | +7.4% | 97,556 | -3.9% | 1.61% | +41.0% |
| Q3 2019 | $4,527,000 | +6.7% | 101,550 | -1.2% | 1.14% | +10.6% |
| Q2 2019 | $4,244,000 | -4.0% | 102,815 | -5.9% | 1.03% | -3.6% |
| Q1 2019 | $4,419,000 | +7.4% | 109,300 | +0.9% | 1.07% | -13.2% |
| Q4 2018 | $4,116,000 | -28.8% | 108,377 | -25.8% | 1.23% | +16.9% |
| Q3 2018 | $5,782,000 | – | 146,134 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |